NeuroSolutions is a contract research organisation established in 2001 as a service provider of cutting edge electrophysiological and behavioural research in the field of neuroscience.
NeuroSolutions has established expertise in delivering first class preclinical translational research into pain, particularly around the development of new treatments into neuropathic and inflammatory pain.
NeuroSolutions has extensive experience in delivering first class preclinical translational research into the study, treatment and prevention of neurodegenerative disorders, particularly around amyloid based animal models of Alzheimer’s disease.
NeuroSolutions has a wealth of experience in providing first class preclinical translational research into the study, treatment and prevention of mental disorders.
NeuroSolutions also has considerable expertise in a number of other key areas of neuroscience, including particular experience in providing first class preclinical translational research into obesity and epilepsy.
Email: info@nsolns.com
Contact Head-office on +44 (0) 8454 500171
One of our partner companies may be better suited to your requirements